Bank Of America Corp Reviva Pharmaceuticals Holdings, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 3,945 shares of RVPH stock, worth $3,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,945
Previous 21,929
82.01%
Holding current value
$3,629
Previous $82,000
93.9%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RVPH
# of Institutions
38Shares Held
6.77MCall Options Held
256KPut Options Held
77.1K-
Woodline Partners LP San Francisco, CA1.59MShares$1.47 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.24MShares$1.14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$943,2290.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.01MShares$932,6870.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT505KShares$464,2320.1% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $18.8M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...